Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease
J Schultheiss(University Medical Center Utrecht), Bas Oldenburg(University Medical Center Utrecht), Michiel T. van der Kaaij(University Medical Center Utrecht), Boris P. van Hellemondt(University Medical Center Utrecht), Nofel Mahmmod(St. Antonius Ziekenhuis), Remi Mahmoud(University Medical Center Utrecht), Bindia Jharap(Meander Medisch Centrum), Petra G. Van Boeckel(St. Antonius Ziekenhuis), Herma H. Fidder(University Medical Center Utrecht), J Louwers(University Medical Center Utrecht)
Cited by 49
Related Papers
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial
|The Lancet Oncology|2011|470
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252